Relation between coronary arterial lesion location and major adverse cardiac events 6-months after an acute coronary syndrome

被引：0
|
作者：
Duarte Rodrigues, J. C. [1 ]
Godinho, A. R. [1 ]
Dias, P. [1 ]
Almeida, R. [1 ]
Viana, M. [2 ]
Laszczynska, O. [2 ]
Araujo, C. [3 ]
Moreira, I. [3 ]
Maciel, M. J. [1 ]
Azevedo, A. [2 ]
机构：
[1] Sao Joao Hosp, Dept Cardiol, Oporto, Portugal
[2] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal
[3] Hosp Ctr Tras Os Montes & Alto Douro, Dept Cardiol, Vila Real, Portugal
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5406
引用
收藏
页码：936 / 936
页数：1
相关论文
共 50 条
  • [31] BRAIN NATRIURETIC PEPTIDE AS A PREDICTOR OF ADVERSE CARDIAC EVENTS AFTER SUCCESSFUL PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Abdelmonem, Y. Y.
    Awni, S.
    Kaddah, A.
    Yazeed, Y.
    CARDIOLOGY, 2013, 125 : 55 - 55
  • [32] The association between Type D personality and major cardiovascular adverse events in acute coronary syndrome patients
    Arslan, Akif
    Demirci, Kadir
    Arslan, Bahriye
    Akgonul, Mehmet
    Kahraman, Fatih
    Aksoy, Fatih
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 14739 - 14743
  • [33] Association of Admission Blood Glucose Level with Major Adverse Cardiac Events in Acute Coronary Syndrome; a Cohort Study
    Alavi-Moghaddam, Mostafa
    Parsa-Mahjoob, Mohammad
    Ghodssi-Ghassemabadi, Robabeh
    Bitazar, Bita
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2019, 7 (01)
  • [34] Hyperuricemia as a Risk Factors of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome: a Retrospective Cohort Study
    Karim, Birry
    Nasution, Sally A.
    Wijaya, Ika P.
    Harimurti, Kuntjoro
    ACTA MEDICA INDONESIANA, 2015, 47 (04) : 320 - 325
  • [35] Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome
    Abergel, Eitan
    Nikolsky, Eugenia
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 963 - 977
  • [36] IL-6 and HMGB1 Levels for Predicting Major Adverse Vascular Events after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
    He, Wujian
    Liu, Yufang
    Liu, Jia
    Feng, Jinke
    Li, Jinyang
    Lin, Ling
    HEART SURGERY FORUM, 2024, 27 (08): : E960 - E967
  • [37] Intramural Coronary Arterial Course Is Associated With Coronary Arterial Stenosis and Prognosis of Major Cardiac Events
    Wang, Yibo
    Lv, Bin
    Chen, Jinxing
    Zhang, Yu
    Luo, Fang
    Lu, Na
    Sun, Kai
    Hou, Zhihui
    Cao, Huili
    Zeb, Irfan
    Budoff, Matthew
    Hui, Rutai
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (02) : 439 - +
  • [38] Myotrophin predicts risk of major adverse cardiac events following acute coronary syndromes
    Khan, S.
    Kelly, D.
    Quinn, P.
    Ng, L.
    HEART, 2006, 92 : A48 - A49
  • [39] The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease
    Khoury, Hanane
    Lavoie, Louis
    Welner, Sharon
    Folkerts, Kerstin
    CARDIOVASCULAR THERAPEUTICS, 2016, 34 (02) : 115 - 124
  • [40] Correlation between monocyte to high-density lipoprotein ratio and major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
    Yu, Rong
    Hou, Ruigang
    Wang, Tong
    Li, Tianliang
    Han, Huiyuan
    An, Jian
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (03) : 885 - 889
12345